Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CORCEPT THERAPEUTICS INC | Financial_Report.xls |
| EX-31.1 - RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER - CORCEPT THERAPEUTICS INC | d404686dex311.htm |
| EX-31.2 - RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CHIEF FINANCIAL OFFICER - CORCEPT THERAPEUTICS INC | d404686dex312.htm |
| EX-32.1 - 18 U.S.C. SECTION 1350 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER - CORCEPT THERAPEUTICS INC | d404686dex321.htm |
| EX-10.1 - PURCHASE AND SALE AGREEMENT - CORCEPT THERAPEUTICS INC | d404686dex101.htm |
| 10-Q - FORM 10-Q - CORCEPT THERAPEUTICS INC | d404686d10q.htm |
Exhibit 32.2
Corcept Therapeutics Incorporated
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Corcept Therapeutics Incorporated (the “Company”) on Form 10-Q for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, G. Charles Robb, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ G. Charles Robb |
| G. Charles Robb |
| Chief Financial Officer |
| November 8, 2012 |